CD4+IL-17A+ TALs restimulated in ovarian cancer conditioned medium, but not in the presence of Th17-driving cytokines or TGFβ, demonstrate increased production of IL-10 (Fig. 7g). This evidence concerns the gene IL17A and ovarian carcinoma.